Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Drug repurposing in cancer
L Sleire, HE Førde, IA Netland, L Leiss, BS Skeie… - Pharmacological …, 2017 - Elsevier
Cancer is a major health issue worldwide, and the global burden of cancer is expected to
increase in the coming years. Whereas the limited success with current therapies has driven …
increase in the coming years. Whereas the limited success with current therapies has driven …
The impact of matrix metalloproteinase-9 on the sequential steps of the metastatic process
G Barillari - International journal of molecular sciences, 2020 - mdpi.com
In industrialized countries, cancer is the second leading cause of death after cardiovascular
disease. Most cancer patients die because of metastases, which consist of the self …
disease. Most cancer patients die because of metastases, which consist of the self …
Old wine in new bottles: Drug repurposing in oncology
M Antoszczak, A Markowska, J Markowska… - European Journal of …, 2020 - Elsevier
Increasing costs, much time consumption and high risk of failure associated with the process
of de novo development of new anticancer drugs have prompted the pharmaceutical …
of de novo development of new anticancer drugs have prompted the pharmaceutical …
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Cancer poses a significant global health challenge, with predictions of increasing
prevalence in the coming years due to limited prevention, late diagnosis, and inadequate …
prevalence in the coming years due to limited prevention, late diagnosis, and inadequate …
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
F Fontana, P Limonta - Free Radical Biology and Medicine, 2021 - Elsevier
Mitochondria are the cytoplasmic organelles mostly known as the “electric engine” of the
cells; however, they also play pivotal roles in different biological processes, such as cell …
cells; however, they also play pivotal roles in different biological processes, such as cell …
[HTML][HTML] Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer invasion and metastasis by regulating epithelial-mesenchymal transition
W Li, G Jia, Y Qu, Q Du, B Liu, B Liu - Medical science monitor …, 2017 - ncbi.nlm.nih.gov
Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and
Metastasis by Regulating Epithelial-Mesenchymal Transition - PMC Back to Top Skip to main …
Metastasis by Regulating Epithelial-Mesenchymal Transition - PMC Back to Top Skip to main …
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers
M Alzahrani, C Stober, M Liu, A Awan, TL Ng… - Supportive Care in …, 2022 - Springer
Background The effect of longer-term use of bone-modifying agent (BMA) on symptomatic
skeletal event (SSE) rates in patients with bone metastases remains unclear. This …
skeletal event (SSE) rates in patients with bone metastases remains unclear. This …
Clinical therapy of metastatic spinal tumors
J Li, W Wei, F Xu, Y Wang, Y Liu, C Fu - Frontiers in Surgery, 2021 - frontiersin.org
Metastatic spinal tumors (MST) have high rates of morbidity and mortality. MST can destroy
the vertebral body or compress the nerve roots, resulting in an increased risk of pathological …
the vertebral body or compress the nerve roots, resulting in an increased risk of pathological …
Proteases regulate cancer stem cell properties and remodel their microenvironment
A Habič, M Novak, B Majc… - … of Histochemistry & …, 2021 - journals.sagepub.com
Proteolytic activity is perturbed in tumors and their microenvironment, and proteases also
affect cancer stem cells (CSCs). CSCs are the therapy-resistant subpopulation of cancer …
affect cancer stem cells (CSCs). CSCs are the therapy-resistant subpopulation of cancer …
Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone …
H Zhao, G Pond, D Simos, Z Wang, S Robertson… - Cancers, 2023 - mdpi.com
Simple Summary The current study was a retrospective exploratory study evaluating
whether circulating levels of known targets of doxycycline were altered following …
whether circulating levels of known targets of doxycycline were altered following …